[The prevention of postinfarction left ventricular dilatation by captopril]

Area of Science:

• Cardiology
• Pharmacology

Background:

• Myocardial infarction (MI) frequently leads to left ventricular dysfunction.
• Left ventricular ejection fraction (EF) < 40% indicates significant cardiac impairment post-MI.
• Early intervention is crucial for improving outcomes in post-MI patients.

Purpose of the Study:

• To evaluate the efficacy of captopril in improving left ventricular function after myocardial infarction.
• To compare the effects of captopril and nifedipine versus conventional treatment on cardiac function.
• To assess changes in ejection fraction and ventricular dimensions over 12 months.

Main Methods:

• Thirty patients with first MI and EF < 40% were randomized into three groups.
• Group 1 received captopril, Group 2 received nifedipine, and Group 3 received conventional care.
• Echocardiography, ejection fraction measurements, and treadmill stress tests were performed at baseline and follow-up points (1, 6, 12 months).

Main Results:

• Captopril group (Group 1) showed a significant increase in EF from 38% to 54% at 6 months (p < 0.01) and 60% at 12 months (p < 0.005).
• Nifedipine (Group 2) and conventional treatment (Group 3) showed more modest improvements in EF.
• Group 3 showed a significant increase in EF from 41% to 50% at 12 months (p < 0.05).

Conclusions:

• Captopril significantly enhances left ventricular ejection fraction in patients recovering from myocardial infarction.
• Captopril demonstrates superior efficacy compared to nifedipine and conventional therapy in improving cardiac function post-MI.
• Long-term captopril treatment is beneficial for cardiac remodeling and function after myocardial infarction.